Temporomandibular Joint (TMJ) Positioning Accuracy and Efficiency Using a Dental Compass.

February 4, 2025 updated by: Dr. Dean Reeves, Dr. Dean Reeves Clinic

Improving TMJ Joint Positioning and Accuracy With Therapeutic Splint Fabrication Using a Dental Compass While Reducing Radiation Exposure: A Cohort Comparison

This study is being performed to determine if the use of the Dental Compass Articular and its software will produce therapeutic splints for TMD accurately and successfully, compare favorably with a cohort treated without the Dental Compass (for number of visits, splint modifications, and required CBCTs).

Study Overview

Detailed Description

Standard practice in the treatment of temporomandibular dysfunction (TMD) currently involves non-radiographically-assisted manual repositioning of the jaw followed by either an in-office cone beam computerized tomography (CBCT) or tomographic X-ray of both TMJs, and further adjustment as necessary to improve the initial bite impression.[15] At follow up visits the therapeutic splint is modified in stages to "walk" the condyle progressively into the ideal position, such as altering side shift, lateral deviation, and rotation. During this process multiple CBCTs or tomographic X-rays, and multiple direct dentist interventions, are required to find the precise joint position, involving significant radiation exposure, and significant chair time for the dentist

The key advantage of using the Dental Compass Articulator in conjunction with its software, is to identify and suggest corrections for the range of orthopedic imbalances present. Software-facilitated identification of imbalances is coupled with manipulation of yaw (anterior, posterior, lateral, or rotational movement of the mandible in a horizontal plane), pitch (rotation of the mandible in a frontal vertical plane), and roll (rotation of the mandible in a lateral vertical plane) to achieve optimal condylar and mandibular position for splint manufacture.

The goals of this study are to:

  1. Determine if the use of the Dental Compass Articular and its software will produce therapeutic splints for TMD accurately and successfully, and will compare favorably with a cohort treated without the Dental Compass (for number of visits, splint modifications, and required CBCTs), and
  2. Confirm a clinically important reduction in airway constriction and improvement in airway volume with us of the therapeutic splint.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Texas
      • Gainesville, Texas, United States, 76240
        • Recruiting
        • Skalff Dental Studio and Technologies 103 C West Broadway Street #3736
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria for prospective active participants:

  • TMJ dysfunction and pain
  • CBCT indicates a non-Gelb 4/7 position or < 1.8 mm bone to bone interval between the mandibular condyle and mandibular fossa anteriorly or posteriorly.

Exclusion Criteria:

  • Planning a move within 9 months.
  • Unwilling to provide two phone numbers and two email contacts.
  • Not willing to express a willingness to come in for 4-6 month follow up if they have marked improvement or improvement in symptoms.
  • Not living within 90-minute drive from clinic
  • Transportation not reliable
  • Involved in any other TMD study
  • Life threatening illness or major surgery planned
  • Other major life stress that might interfere with completing the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 3D Analysis Group
Compass Use
Dental Compass and Dental Compass software used for therapeutic splint fabrication
Active Comparator: Manual Analysis Cohort
Manual Use only
Manual methods used for therapeutic splint fabrication

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of clinic visits
Time Frame: 3-6 months
Number of clinic visits from initial evaluation to confirmation of final therapeutic splint provision
3-6 months
Number of cone beam CTs (CBCTs)
Time Frame: 3-6 months
Number of CBCTs obtained from initial evaluation to confirmation of final therapeutic splint provision
3-6 months
Number of splint modifications
Time Frame: 3-6 months
Number of splint modifications obtained from initial evaluation to confirmation of final therapeutic splint provision
3-6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gelb 4/7 position achieved during treatment (3D group only)
Time Frame: 3-6 months
Yes or no for Gelb 4/7 position
3-6 months
Anterior joint space of 1.8 mm or more achieved during treatment (3D group only)
Time Frame: 3-6 months
Yes or no for anterior joint space of 1.8 mm or more
3-6 months
Posterior joint space of 1.8 mm or more achieved during treatment (3D group only)
Time Frame: 3-6 months
Yes or no for posterior joint space of 1.8 mm or more
3-6 months
Improvement in total airway volume
Time Frame: 3-6 months
Change in total airway volume from use of TMJ splint
3-6 months
Improvement in minimum airway diameter
Time Frame: 3-6 months
Change in total airway volume from use of TMJ splint
3-6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kenneth D Reeves, MD, K. Dean Reeves, M.D., P.A.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 8, 2024

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

September 27, 2024

First Submitted That Met QC Criteria

September 27, 2024

First Posted (Actual)

October 1, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 4, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All non identifying data

IPD Sharing Time Frame

Indefinitely

IPD Sharing Access Criteria

By email request to P.I. at DeanReevesMD@gmail.com

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Joint Syndrome

Clinical Trials on 3D Analysis Group

Subscribe